Medtronic Stent Approved to Treat Coronary Artery Disease

Including people with diabetes

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

TUESDAY, Feb. 21, 2012 (HealthDay News) -- Medtronic's Resolute Integrity Drug-Eluting Stent has been approved by the U.S. Food and Drug Administration for people with coronary artery disease (CAD), the Minneapolis-based company said in a news release.

A stent is a hollow mesh tube used to prop open a narrowed coronary vessel. Medtronic's Resolute Integrity DES is made from a drug-coated polymer material and resembles a flexible spring,

The device performed strongly in clinical studies, including among people with diabetes, a common contributor to CAD, Medtronic said.

CAD is the leading cause of death in the United States, killing almost 500,000 people annually, the company said.

More information

Medline Plus has more about coronary artery disease.

--

Last Updated:

Related Articles